Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2 MM model of multiple myeloma

Peter I. Croucher; Claire M. Shipman; M. Perry; J. Lippitt; Kewal Asosingh; E. Van Beek; Benjamin Van Camp; Graham G. Russell; C. Dunstan; Karin Vanderkerken

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2 MM model of multiple myeloma

Peter I. Croucher, Claire M. Shipman, M. Perry, J. Lippitt, Kewal Asosingh, E. Van Beek, Benjamin Van Camp, Graham G. Russell, C. Dunstan, Karin Vanderkerken

Research output: Contribution to journal › Editorial

Original language	English
Journal	Blood
Volume	96
Publication status	Published - 2000

Bibliographical note

Blood 96: 761a, 2000

Handle.net

Persistent link

Cite this

@article{b4fd558aa379487094679cea6d5520c2,

title = "Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2 MM model of multiple myeloma",

author = "Croucher, {Peter I.} and Shipman, {Claire M.} and M. Perry and J. Lippitt and Kewal Asosingh and {Van Beek}, E. and {Van Camp}, Benjamin and Russell, {Graham G.} and C. Dunstan and Karin Vanderkerken",

note = "Blood 96: 761a, 2000",

year = "2000",

language = "English",

volume = "96",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2 MM model of multiple myeloma

AU - Croucher, Peter I.

AU - Shipman, Claire M.

AU - Perry, M.

AU - Lippitt, J.

AU - Asosingh, Kewal

AU - Van Beek, E.

AU - Van Camp, Benjamin

AU - Russell, Graham G.

AU - Dunstan, C.

AU - Vanderkerken, Karin

N1 - Blood 96: 761a, 2000

PY - 2000

Y1 - 2000

M3 - Editorial

SN - 0006-4971

VL - 96

JO - Blood

JF - Blood

ER -